| abstract |
In particular, the invention relates to respiratory fusion virus (RSV) proteins, modified RSV proteins, and nucleic acids and vectors encoding one or more of them. The invention also provides compositions, including immunogenic compositions, pharmaceutical compositions, and vaccines. The compositions, nucleic acids, vectors and polypeptides of the invention can be used to induce an immune response to RSV or RSV proteins and/or to treat or inhibit RSV infection in an animal. |